Literature DB >> 12470633

Leucine promotes glucose uptake in skeletal muscles of rats.

Shinobu Nishitani1, Tsuyoshi Matsumura, Shoji Fujitani, Ichiro Sonaka, Yutaka Miura, Kazumi Yagasaki.   

Abstract

Soleus muscles isolated from normal rats were incubated to evaluate whether or not leucine promotes glucose uptake under insulin-free conditions, using a labeled 2-deoxyglucose uptake assay. Glucose uptake was promoted by 2mM leucine. A metabolite of leucine, alpha-ketoisocaproic acid (alpha-KIC), also exhibited a similar stimulatory effect, although this was not as potent as leucine. Stimulation of glucose uptake by leucine was completely canceled by pre-treatment with either 10 microM LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (PI3-kinase), or 6 microM GF109203X, a specific inhibitor of protein kinase C (PKC). No significant change was observed by pre-treatment with 1 microM rapamycin, a specific inhibitor of mammalian target of rapamycin (mTOR). These results suggest that leucine stimulates glucose transport in skeletal muscle via PI3-kinase and PKC pathways independently of the mammalian target of mTOR. They also suggest that leucine stimulates glucose transport by an insulin-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470633     DOI: 10.1016/s0006-291x(02)02717-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

1.  Ketoisocaproic acid, a metabolite of leucine, suppresses insulin-stimulated glucose transport in skeletal muscle cells in a BCAT2-dependent manner.

Authors:  Mahshid Moghei; Pegah Tavajohi-Fini; Brendan Beatty; Olasunkanmi A J Adegoke
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

2.  Mechanisms for antidiabetic effect of gingerol in cultured cells and obese diabetic model mice.

Authors:  Myoung Jin Son; Yutaka Miura; Kazumi Yagasaki
Journal:  Cytotechnology       Date:  2014-05-04       Impact factor: 2.058

Review 3.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 4.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-30

5.  Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus.

Authors:  Masahiro Kobayashi; Kenji Ikeda; Yasuji Arase; Yoshiyuki Suzuki; Fumitaka Suzuki; Norio Akuta; Tetsuya Hosaka; Naoya Murashima; Satoshi Saitoh; Takashi Someya; Akihito Tsubota; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

Review 6.  Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids.

Authors:  Ikuo Nakamura
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

7.  Quantification of branched-chain keto acids in tissue by ultra fast liquid chromatography-mass spectrometry.

Authors:  Kristine C Olson; Gang Chen; Christopher J Lynch
Journal:  Anal Biochem       Date:  2013-05-14       Impact factor: 3.365

Review 8.  Branched-chain amino acid supplementation: impact on signaling and relevance to critical illness.

Authors:  John S A Mattick; Kubra Kamisoglu; Marianthi G Ierapetritou; Ioannis P Androulakis; Francois Berthiaume
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-03-29

9.  Endoplasmic reticulum retention signaling and transmembrane channel proteins predicted for oilseed ω3 fatty acid desaturase 3 (FAD3) genes.

Authors:  Mohammad Fazel Soltani Gishini; Alireza Zebarjadi; Maryam Abdoli-Nasab; Mokhtar Jalali Javaran; Danial Kahrizi; David Hildebrand
Journal:  Funct Integr Genomics       Date:  2019-11-28       Impact factor: 3.410

10.  β2-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling.

Authors:  Robert A Ngala; Jacqueline F O'Dowd; Claire J Stocker; Michael A Cawthorne; Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.